Unlock instant, AI-driven research and patent intelligence for your innovation.

A fluorescent compound for detecting nerve damage and its application

A technology for compounds and neurological disorders, applied in the field of medicine, can solve problems such as poor penetration of excitation and emission light, low fluorescence quantum yield, short absorption and emission wavelengths, etc., achieve high economy and environmental protection, and simple preparation process , the effect of less waste

Active Publication Date: 2021-06-22
THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past few years, a number of fluorescent compounds for detecting Aβ plaques have been reported, but generally the absorption and emission wavelengths are too short, which makes the tissue penetration of the excitation and emission light poor and binds to Aβ plaques. The post-fluorescence quantum yield is not high, and the detection accuracy is poor, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A fluorescent compound for detecting nerve damage and its application
  • A fluorescent compound for detecting nerve damage and its application
  • A fluorescent compound for detecting nerve damage and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Example 1: 2-(4-(9-(diethylamino)-1H-imidazo[4,5-f][1,10]phenanthrolin-2-yl)benzylidene)malononitrile (Compound 1)

[0055]

[0056] Step 1: Dissolve 2-bromo-1,10-phenanthroline-5,6-one) (10.0mmol), potassium carbonate (20.0mmol) and diethylamine (11.0mmol) in 30mL DMF, heat with stirring React at 100°C for 2h, and monitor the progress of the reaction by TLC. Cool to room temperature after the reaction, add 200mL of water to precipitate the solid, wash the filter cake twice with water, and then recrystallize with ethanol to obtain 2-(diethylamino)-1,10-phenanthroline-5 , 6-diketone 2.03g, yield: 72.3%. MS (ESI) M+H: 282.

[0057] Step 2: Dissolve terephthalaldehyde (5.0mmol) and ammonium acetate (50mmol) in 40mL of glacial acetic acid, heat to reflux with stirring, then slowly add 2-(diethylamino)-1,10-phenanthrene A solution of roline-5,6-dione (5.0 mmol) dissolved in 10 mL of glacial acetic acid was continued for 3 h under reflux after the drop was completed, a...

Embodiment 2

[0063] Example 2: 2-(4-(9-(pyrrolidin-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline-2-yl)benzylidene)propane Dinitrile (Compound 2)

[0064]

[0065] Step 1: Dissolve 2-bromo-1,10-phenanthroline-5,6-one) (10.0mmol), potassium carbonate (20.0mmol) and tetrahydropyrrole (11.0mmol) in 30mL DMF, heat with stirring React at 100°C for 4h, and monitor the progress of the reaction by TLC. Cool to room temperature after the reaction, add 150mL of water to precipitate the solid, filter and wash the filter cake twice with water, and recrystallize with methanol to obtain 2-(pyrrolidin-1-yl)-1,10-phenanthroline -5,6-dione 2.27g, yield: 81.4%. MS (ESI) M+H: 280.

[0066] Step 2: Dissolve terephthalaldehyde (5.0mmol) and ammonium acetate (50mmol) in 50mL of glacial acetic acid, heat to reflux with stirring, then slowly add 2-(pyrrolidin-1-yl)-1,10 - A solution of phenanthroline-5,6-dione (5.0mmol) dissolved in 15mL of glacial acetic acid, and continued to reflux for 5h after the drop wa...

Embodiment 3

[0072] Example 3: Absorption and Fluorescence Spectra of Compounds of the Invention.

[0073] Taking compound 2 as an example, the absorption and fluorescence spectra of the compounds of the present invention in different solvents were tested.

[0074] Compound 2 was dissolved in dimethyl sulfoxide to prepare a 10 mM stock solution, and stored in a refrigerator at 4° C. in the dark for future use. Take 10 μL of the mother solution, dilute it to a concentration of 10 μM with DMSO, ethanol and PBS, and measure its absorption spectrum, the results are as follows: figure 1 shown. The maximum absorption wavelengths of compound 2 in DMSO, ethanol and PBS are 607nm, 603nm and 611nm respectively.

[0075] Excited with light at 610nm, the fluorescence spectrum of compound 2 was tested, and the results were as follows figure 2 shown. The maximum emission wavelengths of compound 2 in DMSO, ethanol and PBS are 686nm, 685nm and 663nm, respectively.

[0076] The above experimental re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
absorption wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention provides a fluorescent compound for detecting nerve damage. The compound of the present invention has a maximum absorption and emission wavelength close to or located in the near-infrared, and the excitation and emission light during detection can penetrate human or animal tissues with low loss, which is conducive to improving detection accuracy; its fluorescence is greatly enhanced after being combined with Aβ , and has a certain degree of red shift, and is easy to pass through the blood-brain barrier, so it is particularly suitable for detecting Aβ-plaques in humans or animals, thereby detecting nerve damage caused by Aβ-plaques. In addition, the compound of the present invention has simple preparation process, easy operation, less three wastes, cheap and easy-to-obtain raw materials, and is highly economical and environmentally friendly.

Description

technical field [0001] The invention relates to the field of medical technology, in particular, the invention relates to a fluorescent compound for detecting nerve damage, and the invention also relates to the application of said compound in detecting nerve damage. Background technique [0002] Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive development. Clinically, it is characterized by generalized dementia such as memory impairment, aphasia, apraxia, agnosia, impairment of visuospatial skills, executive dysfunction, and personality and behavior changes. Those with onset before the age of 65 are called Alzheimer's disease; those with onset after the age of 65 are called senile dementia. Due to the complex etiology of Alzheimer's disease, the exact pathogenesis is still unclear. Clinically, it is mainly diagnosed by evaluating the cognitive impairment of patients. Most of the diagnosed patients have entered the middle and late s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/14C09K11/06A61K31/4375A61P25/28A61K49/00
CPCA61K49/0021A61P25/28C07D471/14C09K11/06C09K2211/1007C09K2211/1029C09K2211/1074
Inventor 陈大庆张开睿张宏宇吴芳芳滕陈怀刘雷许可张曼张新博张仁侃
Owner THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE